Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 49 publications
BRCA genetic testing and treatment patterns for patients with HER2-negative early-stage breast cancer in the US community setting.
Journal: Frontiers in oncology
Published: October 22, 2025
Real-world perioperative treatment patterns and economic burden of recurrence in early-stage HER2-negative breast cancer: a SEER-Medicare study.
Journal: Journal of medical economics
Published: December 09, 2024
Correlation Between Disease-Free Survival Endpoints and Overall Survival in Elderly Patients with Early-Stage HER2-Negative Breast Cancer: A SEER-Medicare Analysis.
Journal: Advances in therapy
Published: September 20, 2024
Immunotherapy for hormone receptor‒positive HER2-negative breast cancer.
Journal: NPJ breast cancer
Published: May 01, 2024
Systemic therapy, survival and end-of-life costs for metastatic triple-negative breast cancer: retrospective SEER-Medicare study of women age ≥65 years.
Journal: Future oncology (London, England)
Published: March 25, 2021
Durable Response to PD1 Inhibitor Pembrolizumab in a Metastatic, Metaplastic Breast Cancer.
Journal: Case reports in oncology
Published: February 04, 2021
The role of chromodomain helicase DNA binding protein 1 (CHD1) in promoting an invasive prostate cancer phenotype.
Journal: Therapeutic advances in urology
Published: December 29, 2020
Early triple-negative breast cancer in women aged ≥65: retrospective study of outcomes, resource use and costs, 2010-2016.
Journal: Future oncology (London, England)
Published: December 02, 2020
Targetable alterations in invasive pleomorphic lobular carcinoma of the breast.
Journal: Breast cancer research : BCR
Published: November 13, 2020
Hodgkin Lymphoma and Cutaneous T-Cell Lymphoma Sharing the PCM1-JAK2 Fusion and a Common T-Cell Clone.
Journal: JCO precision oncology
Published: October 11, 2019
Last Updated: 09/26/2026